(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.

AI Fears Mount on CEO Calls for Slowdown
22:26

OpenAI Says It’s Working With Anthropic, Google on AI Safety
07:54

AI Bosses Risk Clash With Wall Street and Trump Over Safety
21:45